Doç. Dr. Sema Seçilmiş

Initial clinical and laboratory findings of patients diagnosed with HIV in a hematology outpatient clinic: a retrospective analysis

Journal of Health Sciences and Medicine, 2026

DOI 10.32322/jhsm.1783841 Frei zugänglicher VolltextQuelle: OpenAlex

Impact of Dyslipidemia on Allogeneic Transplantation Outcomes and Cardiovascular Mortality in Patients with Acute Leukemias in the Post-Transplant Cyclophosphamide Era

Pharmaceuticals (Basel, Switzerland), 2026

DOI 10.3390/ph19040529 PMID 42075786 Frei zugänglicher VolltextQuelle: Europe PMC

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

Journal of clinical medicine, 2026

DOI 10.3390/jcm15020854 PMID 41598791 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

Prognostic value of the CONUT score in newly diagnosed diffuse large B‑cell lymphoma

Oncology Letters, 2026

DOI 10.3892/ol.2026.15805 PMID 42614724 Frei zugänglicher VolltextQuelle: OpenAlex

Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14176239 PMID 40943998 Frei zugänglicher VolltextQuelle: ORCID

Characteristics and Outcomes of Patients with Acute Promyelocytic Leukemia: A Single-center Experience

Acta haematologica oncologica Turcica., 2025

DOI 10.4274/ahot.galenos.2025.2025-6-1 Frei zugänglicher VolltextQuelle: OpenAlex

Cladribine Treatment Outcomes in Hairy Cell Leukemia: A Single-center Experience

Acta haematologica oncologica Turcica., 2025

DOI 10.4274/ahot.galenos.2025.2025-7-4 Frei zugänglicher VolltextQuelle: OpenAlex

LANGERHANS CELL HISTIOCYTOSIS: SINGLE-CENTER EXPERIENCE

Hematology Transfusion and Cell Therapy, 2025

DOI 10.1016/j.htct.2025.106121 Frei zugänglicher VolltextQuelle: OpenAlex

Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Turkish Journal of Hematology, 2024

DOI 10.4274/tjh.galenos.2024.2023.0450 PMID 39501735 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Early Tapering of Cyclosporine Is Feasible in Haploidentical Stem Cell Transplantation: A Single Center Experience

Clinical transplantation, 2024

DOI 10.1111/ctr.15376 PMID 39031699 1 Zitation (Europe PMC) Quelle: ORCID

Evaluation of oral manifestations and head and neck lymphadenopathy in newly diagnosed acute leukemia patients

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 2024

DOI 10.1111/scd.12941 PMID 37994175 Frei zugänglicher VolltextQuelle: ORCID

Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible?

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2024

DOI 10.1016/j.transci.2024.103956 PMID 38810408 Quelle: ORCID

Is Ruxolitinib an Effective and Safe Therapy for Chronic Myeloproliferative Diseases?

Acta Oncologica Turcica, 2024

DOI 10.5505/aot.2023.46656 Frei zugänglicher VolltextQuelle: OpenAlex

Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Turkish Journal of Hematology, 2023

DOI 10.4274/tjh.galenos.2023.2023.0029 PMID 37961952 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Uric Acid and Multiple Myeloma, Unexplored Association

Acta Oncologica Turcica, 2023

DOI 10.5505/aot.2023.25901 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Characteristics and Outcome of Patients with Chronic Myelomonocytic Leukemia: Experience of a Single Center

Acta Oncologica Turcica, 2023

DOI 10.5505/aot.2023.20082 Frei zugänglicher VolltextQuelle: OpenAlex

Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience

PubMed, 2022

DOI 10.26355/eurrev_202205_28843 PMID 35647829 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Pregnancy outcomes in female cancer survivors after hematopoietic stem cell transplantation

PubMed, 2022

DOI 10.26355/eurrev_202202_28008 PMID 35179765 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Transformed Lymphomas: Is It Really Rare ?

Acta Oncologica Turcica, 2022

DOI 10.5505/aot.2022.56689 Frei zugänglicher VolltextQuelle: OpenAlex

Immune Thrombocytopenia: A Disease With Many Unresolved Questions

Acta Oncologica Turcica, 2022

DOI 10.5505/aot.2022.89166 Frei zugänglicher VolltextQuelle: OpenAlex

Evaluation of seasonality in the diagnosis of diffuse large B cell lymphoma in Turkey

Journal of Health Sciences and Medicine, 2021

DOI 10.32322/jhsm.828027 Frei zugänglicher VolltextQuelle: ORCID

Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma

Leukemia research, 2021

DOI 10.1016/j.leukres.2021.106700 PMID 34481125 8 Zitationen (Europe PMC) Quelle: ORCID

Combination of Venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia: A case series from a single center.

PubMed, 2021

PMID 34761613 1 Zitation (OpenAlex) Quelle: OpenAlex

Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations

Medicine, 2020

DOI 10.1097/md.0000000000019627 PMID 32243389 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020

Quelle: ORCID

One Year Remission with Allogeneic Stem Cell Transplantation After Achieving Complete Response by Polatuzumab Vedotin for the Treatment of Refractory Diffuse Large B-Cell Lymphoma

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020

Quelle: ORCID

The Coexistence of Hyperimmunoglobulin E Syndrome and Myelodysplastic Syndrome

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020

Quelle: ORCID

AML-360: The Coexistence of Hyperimmunoglobulin E Syndrome and Myelodysplastic Syndrome

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/s2152-2650(20)30767-9 Quelle: OpenAlex

AML-212: Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/s2152-2650(20)30735-7 Quelle: OpenAlex

ABCL-037: One Year Remission with Allogeneic Stem Cell Transplantation After Achieving Complete Response by Polatuzumab Vedotin for the Treatment of Refractory Diffuse Large B-Cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/s2152-2650(20)30864-8 Quelle: OpenAlex

Behcet's disease and IgA nephropathy

Rheumatology international, 2012

DOI 10.1007/s00296-011-2051-3 PMID 21785954 10 Zitationen (Europe PMC) Quelle: ORCID

QT INTERVAL DISPERSION AMONG CHRONIC AMBULATORY PERITONEAL DIALYSIS PATIENTS AND ASSOCIATION WITH IRON STORES

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012

Quelle: ORCID

Mucocutaneous manifestations in inflammatory bowel disease

Inflamm Bowel Dis, 2009

DOI 10.1002/ibd.20807 PMID 19023896 52 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Pro-Hepcidin Levels in Peritoneal Dialysis and Hemodialysis Patients

Dialysis & Transplantation, 2009

DOI 10.1002/dat.20297 5 Zitationen (OpenAlex) Quelle: ORCID

Endoscopic Sphincteroplasty with Large Balloon Dilatation for Extraction of Difficult Common Bile Duct Stones

Digestive Diseases and Sciences, 2007

DOI 10.1007/s10620-007-0060-6 PMID 17940901 10 Zitationen (OpenAlex) Quelle: OpenAlex

Hepatotoxicity after low-dose cyclophosphamide therapy

Southern medical journal, 2006

DOI 10.1097/01.smj.0000251467.62842.ad PMID 17233202 15 Zitationen (Europe PMC) Quelle: ORCID